Contineum Therapeutics, Inc. (CTNM): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

27.70M
Year ended 2025-12-31
2023-12-31: 3.40M2024-12-31: 19.35M2025-12-31: 27.70M27.70M
2023-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3127.70M+43.1%2026-03-05, From 2025-01-01
2024-12-3119.35M+470.0%2026-03-05, From 2024-01-01
2023-12-313.40Mn/a2025-03-06, From 2023-01-01